ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Grey Wolf Therapeutics Limited

Grey Wolf Therapeutics Limited is an active company incorporated on 29 September 2017 with the registered office located in Abingdon, Oxfordshire. Grey Wolf Therapeutics Limited was registered 8 years ago.
Status
Active
Active since incorporation
Company No
10989365
Private limited company
Age
8 years
Incorporated 29 September 2017
Size
Large
Did not meet the 2-out-of-3 criteria for Medium size or smaller.
Confirmation
Overdue
Confirmation statement overdue by 73 days
Dated 27 October 2024 (1 year 2 months ago)
Next confirmation dated 27 October 2025
Was due on 10 November 2025 (2 months ago)
Last change occurred 1 year 2 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
99 Park Drive
Milton
Abingdon
OX14 4RY
England
Address changed on 4 Aug 2022 (3 years ago)
Previous address was Clarendon Business Centre 57 Woodstock Road Oxford OX2 6HJ England
Telephone
01235 644970
Email
Unreported
People
Officers
10
Shareholders
44
Controllers (PSC)
1
Director • Australian • Lives in UK • Born in Jun 1967
Director • French • Lives in UK • Born in Aug 1966
Director • British • Lives in England • Born in Apr 1982
Director • American • Lives in United States • Born in Jul 1969
Director • French • Lives in France • Born in Apr 1970
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Pathios Therapeutics Limited
Brenton Karl Ahrens and Thomas David McCarthy are mutual people.
Active
Utak1 Bio Limited
Thomas David McCarthy is a mutual person.
Active
Oxford Nanoimaging Limited
Dr Ekaterina Smirnyagina is a mutual person.
Active
Curve Therapeutics Limited
Marie-Claire Peakman is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£20.42M
Increased by £11.39M (+126%)
Turnover
Unreported
Same as previous period
Employees
19
Increased by 1 (+6%)
Total Assets
£28.9M
Increased by £13.21M (+84%)
Total Liabilities
-£2.61M
Increased by £284K (+12%)
Net Assets
£26.29M
Increased by £12.92M (+97%)
Debt Ratio (%)
9%
Decreased by 5.8% (-39%)
Latest Activity
Own Shares Purchased
10 Days Ago on 12 Jan 2026
Shares Cancelled
10 Days Ago on 12 Jan 2026
Small Accounts Submitted
1 Month Ago on 15 Dec 2025
Emma Johnson Resigned
1 Month Ago on 10 Dec 2025
Mr Paul John Grattan Stainer Appointed
8 Months Ago on 1 May 2025
Samantha Ann Harris Resigned
10 Months Ago on 1 Mar 2025
Dr Ekaterina Smirnyagina Appointed
1 Year 1 Month Ago on 25 Nov 2024
Sally Marianne Dewhurst Resigned
1 Year 1 Month Ago on 25 Nov 2024
Confirmation Submitted
1 Year 2 Months Ago on 9 Nov 2024
Small Accounts Submitted
1 Year 4 Months Ago on 29 Aug 2024
Get Credit Report
Discover Grey Wolf Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Replacement filing of SH01 - 02/06/25 Statement of Capital gbp 2987.4578
Submitted on 19 Jan 2026
Statement of capital following an allotment of shares on 6 August 2025
Submitted on 14 Jan 2026
Statement of capital following an allotment of shares on 29 May 2025
Submitted on 14 Jan 2026
Purchase of own shares.
Submitted on 12 Jan 2026
Cancellation of shares. Statement of capital on 11 December 2025
Submitted on 12 Jan 2026
Resolutions
Submitted on 20 Dec 2025
Termination of appointment of Emma Johnson as a director on 10 December 2025
Submitted on 19 Dec 2025
Accounts for a small company made up to 31 December 2024
Submitted on 15 Dec 2025
Statement of capital following an allotment of shares on 2 June 2025
Submitted on 19 Jun 2025
Resolutions
Submitted on 4 Jun 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year